The pill can be taken without food or water, its manufacturer says.
An Eli Lilly and Company pharmaceutical manufacturing plant at 50 Imclone Drive in Branchburg, N. J., on March 5, 2021. Mike Segar/Reuters
U.S. regulators on April 1 approved an obesity pill called Foundayo from Eli Lilly, adding a second option for consumers who want to take weight loss drugs but desire to avoid injections.
Foundayo is a glucagon-like peptide-1 (GLP-1) medication meant to be taken once a day.
